Sanofi Reframed Podcast | Boundless: We’re Unstoppable with Yvonne Wick and Nicole Farmer

Introducing the new #SanofiReframed podcast where a member of our Aspiring Leaders Graduate Programme sits down with one of our senior leaders to discuss key issues that they don’t really teach you on the job.

Latest news and articles

lungs asthma

Thought leadership piece for World Asthma Day

FEATURE

May 2022

We’ve been preoccupied with another respiratory health issue over the last two years, and it has made us all think more about breathing, and how breathing well is vital for our health. For World Asthma Day this year, let’s all refocus on closing the gap in asthma care.

Passing the mic to the Pompe community

FEATURE

April 2022

Sanofi is committed to supporting patients and their families living with rare conditions and helping them live the best lives they can. Providing holistic support through community events like Pompe and Circumstance is a vital part of that.

Bridging the digital divide to create more inclusive healthcare

FEATURE

February 2022

The delivery of healthcare has changed in the UK, with the COVID-19 pandemic accelerating the availability and adoption of digital capabilities. This has not only improved how healthcare professionals can interact with and monitor patients but has enabled people to access the care they need in the most challenging of times.

Press Contact

If you are a journalist with an enquiry, please contact the Sanofi UK Media Relations team at +44 (0) 118 354 3554 or click here to submit your question electronically. 

This route is intended for journalists with specific enquiries only. 

More news and articles

Filters

ALL
FEATURE
VIDEO AND AUDIO
FEATURED NEWS
REPORT
OPINION PIECE
State of the Nation: Non-Melanoma Skin Cancer Report
  • FEATURE
  • REPORT
July 15, 2020

Non-melanoma skin cancer (NMSC) is the most common cancer in the UK, yet most people haven’t heard of it, and would struggle to correctly identify its symptoms. Despite the significant physical and emotional distress it can cause, NMSC is still all too often regarded as a minor condition that is easily treatable.

Sanofi’s Response in the Fight against COVID-19
  • FEATURE
July 10, 2020

As the unprecedented COVID-19 pandemic continues to spread around the world, Sanofi is at the forefront of multiple initiatives to fight the disease, while also carrying on the daily business of making and delivering medicines for patients.

Gender pay gap report 2019
  • REPORT
April 29, 2020

Achieving gender balance is a strategic priority for Sanofi.

Health Secretary Rt Hon Matt Hancock MP officially opens Sanofi's new UK headquarters
  • FEATURE
October 30, 2019

Sanofi celebrates grand opening of new UK headquarters at Thames Valley Park in Reading.

Ensuring equality and flexible working is not just a buzzword
  • OPINION PIECE
August 29, 2019

Jessamy Baird, Director of Market Access, shares her thoughts on equality and opportunity at Sanofi UK.

How the net generation will shape the future of self-care
  • OPINION PIECE
August 21, 2019

Millennials are distinctively resourceful when using traditional health support and modern technology to meet their health needs.

Strategic relationship with Catalent underlines Sanofi's commitment to UK manufacturing
  • FEATURE
July 30, 2019

The UK has world leading universities, a highly-skilled workforce and a life sciences ecosystem that has lead discoveries with a huge impact for people and patients all across the world.  However, for the UK to remain a hub for scientific innovation, it is crucial that all those involved in life sciences work together to maintain momentum and investment in the UK, especially when looking to the landscape beyond Brexit.

Collaborating for innovation
  • FEATURE
June 26, 2019

An exciting new alliance has been announced between Sanofi and Oxford University Medical Sciences Division.

The Power of Prevention
  • REPORT
  • FEATURE
January 30, 2019

As the Secretary of State for Health & Social Care has set out, the long-term sustainability of the NHS is reliant on a cultural shift which acknowledges the value of investing in prevention in both principle and practise.

MAT-GB-2001215(v2.0)
Last page update April 2022